3 results
The primary objective of this study is to determine whether the Impella cVAD device vs. IABP therapy leads to a higher 30 day survival rate in shock STEMI patients in the setting of primary PCI.
The primary objective is to test the hypothesis that galcanezumab is superior to placebo in the prevention of migraine in patients with treatment-resistant migraine.The key secondary objective are:- To compare galcanezumab with placebo with respect…
The primary objective of this prospective study in subjects with severe emphysema is to evaluate the utility of the AeriSeal System to occludecollateral air channels in a target lung lobe with collateral ventilation (CV+) and convert the target lung…